Corteva, Inari Settle Seed-Tech Patent Case Days Into Jury Trial

Corteva (CTVA) settled a lawsuit with Inari, resolving a 2023 intellectual property dispute. Inari will remove Corteva materials and return related intellectual property. Corteva's stock is modestly overvalued at $78.56, 17.2% above its GF Value of $67.04, with a GF Score of 81/100. The company is undergoing a strategic separation of its seed business.

Corteva and Inari settled a $1.3 billion seed patent dispute mid-trial. Financial terms were not disclosed, but Inari agreed to destroy Corteva's biological materials. The case was closely watched by the ag-tech industry and the DOJ Antitrust Division.

Corteva and Inari have settled a US patent dispute over seed technology during their trial. The companies reached an agreement, though terms were not disclosed. The case involved patents related to seed genetics and breeding.

Corteva Inc. will pay $35M to 12 states and end its crop loyalty program as part of an FTC settlement, resolving allegations of anti-competitive practices. The agreement prohibits certain purchasing requirements and retaliation against customers. Corteva denies wrongdoing. The settlement does not guarantee payments to farmers. The case against Syngenta continues.

Iowa Attorney General Brenna Bird announced a $35M settlement with Corteva, Inc. over alleged monopoly violations in its pesticide loyalty programs. Iowa will receive $2.4M. The FTC and states claimed Corteva's practices limited competition, raising farmers' costs. The settlement is separate from an $85M class action case involving over 100,000 farmers.

The U.S. Federal Trade Commission (FTC) and several states have secured protections to reduce pesticide prices for American farmers in an antitrust case against Corteva. The agreement aims to lower costs for farmers by addressing competitive concerns in the pesticide market.